The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 02, 2021

Filed:

Feb. 09, 2017
Applicant:

Consiglio Nazionale Delle Ricerche, Rome, IT;

Inventors:

Francesca Cunsolo, Catania, IT;

Tommaso Mecca, Catania, IT;

Rita La Spina, Giarre, IT;

Fabiola Spitaleri, Catania, IT;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
B01D 71/40 (2006.01); B01J 20/26 (2006.01); C08F 220/20 (2006.01); B01J 20/28 (2006.01); B01D 61/24 (2006.01); B01D 71/08 (2006.01); C08J 3/075 (2006.01); C08K 3/16 (2006.01); C08K 3/26 (2006.01); C08K 5/09 (2006.01); C08K 5/10 (2006.01); C08K 5/20 (2006.01); C08L 5/10 (2006.01); C08L 33/14 (2006.01);
U.S. Cl.
CPC ...
B01D 71/40 (2013.01); B01D 61/243 (2013.01); B01D 71/08 (2013.01); B01J 20/261 (2013.01); B01J 20/264 (2013.01); B01J 20/267 (2013.01); B01J 20/28047 (2013.01); C08F 220/20 (2013.01); C08J 3/075 (2013.01); C08K 3/16 (2013.01); C08K 3/26 (2013.01); C08K 5/09 (2013.01); C08K 5/10 (2013.01); C08K 5/20 (2013.01); C08L 5/10 (2013.01); C08L 33/14 (2013.01); B01D 2257/00 (2013.01); C08J 2333/14 (2013.01); C08J 2405/10 (2013.01); C08L 2203/02 (2013.01); C08L 2312/00 (2013.01);
Abstract

The object of the present invention is a new cryopolymerization process that provides crosslinked polymeric materials in the form of a macroporous gel (cryogel) capable of sequestering (neutralize) the anticoagulant heparin, its low molecular weight derivatives (LMWH and ULMWH) and heparinoids, from aqueous solutions, physiological solutions and biological fluids, such as whole blood, serum and plasma. A further object of the invention are also crosslinked polymeric materials in the form of a macroporous gel (cryogel) obtained by the cryopolymerization process of the invention that, thanks to said specific process, result to be comprised of varying proportions of HEMA and HEMA-R monomers. The molar ratio between the components (HEMA/HEMA-R) may vary between 99.9% HEMA:0.1% HEMA-R and 0.1% HEMA:99.9% HEMA-R. Object of the invention is also the use of crosslinked polymeric materials in the form of a macroporous gel (cryogel) obtainable by the cryopolymerization process of the invention for the construction of filters, membranes or devices for the treatment of biological fluids. A further object of the invention are therefore filters, membranes, or devices for the treatment of biological fluids which comprise materials obtained by the cryopolymerization process of the invention.


Find Patent Forward Citations

Quick Actions:

Cunsolo, Francesca. (2021). Cryogel for the removal of heparins and heparinoids from aqueous solutions, physiological solutions and biological fluids, preparation process and uses thereof (U.S. Patent No. 10933384). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10933384

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…